NCT05790707View on ClinicalTrials.gov

EfFect of Ablation of Persistent AtriaL Fibrillation on COgNitive Function in Individuals with Mild Cognitive Impairment

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 21, 2023

Primary Completion Date

January 31, 2027

Study Completion Date

July 31, 2027

Conditions
Mild Cognitive ImpairmentPersistent Atrial Fibrillation
Interventions
PROCEDURE

Atrial fibrillation ablation + antiarrhythmic drugs

"Atrial fibrillation ablation will be performed with endovascular catheters and will be done either with radiofrequency, cryoballoon or pulsed field ablation.~Amiodarone, flecainide, sotalol, propafenone are the anti arrhythmic drugs allowed."

DRUG

Antiarrhythmic drug

Amiodarone, flecainide, sotalol, propafenone are the anti arrhythmic drugs allowed.

Trial Locations (6)

Unknown

NOT_YET_RECRUITING

University Hospital, Brest

NOT_YET_RECRUITING

University Hospital, Caen

NOT_YET_RECRUITING

University Hospital, Dijon

NOT_YET_RECRUITING

Hopital Européen Georges Pompidou, Paris

RECRUITING

University Hospital, Poitiers

NOT_YET_RECRUITING

Centre Cardiologique du Nord, Saint-Denis

All Listed Sponsors
lead

Poitiers University Hospital

OTHER